{"id":15058,"date":"2022-12-22T19:36:10","date_gmt":"2022-12-22T18:36:10","guid":{"rendered":"https:\/\/www.immuninlab.ch\/?page_id=15058"},"modified":"2023-06-27T16:35:55","modified_gmt":"2023-06-27T14:35:55","slug":"auto-anticorps","status":"publish","type":"page","link":"https:\/\/www.immuninlab.ch\/fr\/prestations\/auto-anticorps\/","title":{"rendered":"Auto-anticorps"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_toggle title=&#8221;D\u00e9pistage des collag\u00e9noses (anticorps anti-nucl\u00e9aires (ANA) et anti-cytoplasmes)&#8221;]<strong>Objectif du test<\/strong><br \/>\nMesurer les auto-anticorps associ\u00e9s aux collag\u00e9noses. Les collag\u00e9noses sont des maladies rhumatismales inflammatoires syst\u00e9miques dont l&#8217;\u00e9volution est g\u00e9n\u00e9ralement chronique (maladies syst\u00e9miques du tissu conjonctif). Chaque collag\u00e9nose se caract\u00e9rise par des profils d&#8217;auto-anticorps typiques. Les collag\u00e9noses comprennent :<\/p>\n<ul>\n<li>le lupus \u00e9ryth\u00e9mateux diss\u00e9min\u00e9 (LED)<\/li>\n<li>Syndrome de Sj\u00f6gren (SjS)<\/li>\n<li>Scl\u00e9rose syst\u00e9mique (SSc)<\/li>\n<li>Myosites idiopathiques (auto-immunes)<\/li>\n<li>Collag\u00e9nose mixte (Mixed connective tissue disease, MCTD, ou syndrome de Sharp)<\/li>\n<li>Syndrome de chevauchement (overlap syndrome)<\/li>\n<\/ul>\n<p><strong>Auto-anticorps mesur\u00e9s \u00e0 l&#8217;aide du d\u00e9pistage des anticorps anti-nucl\u00e9aires et anti-cytoplasmiques :<\/strong><\/p>\n<ul>\n<li><strong>Auto-anticorps anti-ADNdb<\/strong><\/li>\n<li><strong>Auto-anticorps anti-histone<\/strong><\/li>\n<li><strong>Auto-anticorps anti-nucl\u00e9osome (anti-chromatine)<\/strong><\/li>\n<li><strong>Auto-anticorps anti-Sm<\/strong><\/li>\n<li><strong>Auto-anticorps anti-prot\u00e9ines-P ribosomales (anti-P0, anti-P1, anti-P2)<\/strong><\/li>\n<li><strong>Auto-anticorps anti-PCNA<\/strong><\/li>\n<li><strong>Auto-anticorps anti-U1nRNP (sous-unit\u00e9s A, C et 68 kDa)<\/strong><\/li>\n<li><strong>Auto-anticorps anti-SSA<\/strong><\/li>\n<li><strong>Auto-anticorps anti-SSB<\/strong><\/li>\n<li><strong>Auto-anticorps anti-Scl70 (anti-topoisom\u00e9rase I)<\/strong><\/li>\n<li><strong>Auto-anticorps anti-CENP-B (anti-centrom\u00e8re B)<\/strong><\/li>\n<li><strong>Auto-anticorps anti-Jo-1<\/strong><\/li>\n<li><strong>Auto-anticorps anti-Mi-2<\/strong><\/li>\n<li><strong>Auto-anticorps anti-PM\/Scl (anti-polymyosite\/scl\u00e9rodermie overlap syndrome-AK))<\/strong><\/li>\n<li><strong>Auto-anticorps anti-Ku<\/strong><\/li>\n<li><strong>Auto-anticorps anti-mitochondries M2 (AMA) (sous-unit\u00e9s E2 PDC, BCOADC et OGDC)<\/strong><\/li>\n<\/ul>\n<p><strong>Fr\u00e9quence<\/strong><\/p>\n<p>Quotidienne<\/p>\n<p><strong>Unit\u00e9 de mesure<\/strong><\/p>\n<p>Titre (immunofluorescence indirecte sur cellules Hep2 fix\u00e9es)<br \/>\nUnit\u00e9s relatives (RE) ou unit\u00e9s internationales (IU) pour les auto-anticorps anti-ADNdb.<\/p>\n<p><strong>Plages de r\u00e9f\u00e9rence<\/strong><\/p>\n<p>Titre &lt; 1:80<br \/>\n&lt; 1 Unit\u00e9s relatives (RE)<\/p>\n<p><strong>Points tarifaires<\/strong><\/p>\n<table border=\"1\">\n<thead>\n<tr>\n<th><\/th>\n<th>Position<\/th>\n<th>P.tarifaires<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Auto-anticorps anti-noyau cellulaire (auto-anticorps<br \/>\nantinucl\u00e9aires, ANA) (qn)<\/td>\n<td>1191.10<\/td>\n<td>45.00<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-ADNdb (qn)<\/td>\n<td>1112.00<\/td>\n<td>46.80<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-histone (ql)<\/td>\n<td>1129.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-nucl\u00e9osome (1er auto-anticorps, rares) (ql)<\/td>\n<td>1192.00<\/td>\n<td>46.80<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-Sm (ql)<\/td>\n<td>1173.00<\/td>\n<td>15.10<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-prot\u00e9ine-P ribosomale (2e auto-anticorps, rares) (ql)<\/td>\n<td>1192.00<\/td>\n<td>46.80<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-PCNA (ql)<\/td>\n<td style=\"text-align: center;\">&#8211;<\/td>\n<td>gratis<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-RNP (ql)<\/td>\n<td>1169.00<\/td>\n<td>15.10<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-SSA\/Ro (ql)<\/td>\n<td>1181.00<\/td>\n<td>15.10<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-SSB\/La (ql)<\/td>\n<td>1183.00<\/td>\n<td>15.10<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-Scl70 (ql)<\/td>\n<td>1171.00<\/td>\n<td>15.10<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-centrom\u00e8res (ql)<\/td>\n<td>1105.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-Jo1, hystidyl-tARN-synth\u00e9tase (ql)<\/td>\n<td>1139.00<\/td>\n<td>18.90<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-Mi-2 (3e auto-anticorps, rares) (ql)<\/td>\n<td>1193.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-PM-Scl (4e auto-anticorps, rares) (ql)<\/td>\n<td>1193.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-Ku (5e auto-anticorps, rares) (ql)<\/td>\n<td>1193.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-mitochondries M2 (ql)<\/td>\n<td>1149.00<\/td>\n<td>19.80<\/td>\n<\/tr>\n<tr>\n<td>TOTAL<\/td>\n<td><\/td>\n<td>466.10<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Domaine de laboratoire : Immunologie<\/p>\n<p><strong>ANALYTIQUE<\/strong><\/p>\n<p><strong>M\u00e9thode<\/strong><\/p>\n<p>Immunofluorescence indirecte sur cellules Hep2 fix\u00e9es<br \/>\nSpotimmunoassay (SIA), d\u00e9tection des auto-anticorps IgG antinucl\u00e9aires et<br \/>\ncytoplasmiques[\/vc_toggle][vc_toggle title=&#8221;D\u00e9pistage des maladies auto-immunes du foie&#8221;]<strong>Objectif du test<\/strong><\/p>\n<p>Mesure des auto-anticorps associ\u00e9s aux maladies auto-immunes du foie. Apr\u00e8s<br \/>\navoir exclu une pathogen\u00e8se h\u00e9patique virale, la d\u00e9tection d&#8217;auto-anticorps dirig\u00e9s contre des antig\u00e8nes h\u00e9patiques sp\u00e9cifiques est essentielle pour diagnostiquer les maladies h\u00e9patiques auto-immunes. Parmi les maladies auto-immunes du foie, on distingue l&#8217;h\u00e9patite auto-immune (HAI) de type I et II et la cholangite biliaire primitive (CBP). Des syndromes de chevauchement de l&#8217;HAI et de la CBP sont \u00e9galement connus.<\/p>\n<p>Anticorps mesur\u00e9s par le d\u00e9pistage des maladies auto-immunes du foie :<\/p>\n<p><strong>Anticorps associ\u00e9s \u00e0 l&#8217;h\u00e9patite auto-immune :<\/strong><\/p>\n<ul>\n<li><strong>Auto-anticorps anti-F-actine<\/strong><\/li>\n<li><strong>Auto-anticorps anti-SLA<\/strong><\/li>\n<li><strong>Auto-anticorps anti-LKM1<\/strong><\/li>\n<li><strong>Auto-anticorps anti-LC1<\/strong><\/li>\n<\/ul>\n<p><strong>Anticorps associ\u00e9s \u00e0 la cholangite biliaire primitive :<\/strong><\/p>\n<ul>\n<li><strong>Auto-anticorps anti-mitochondries (anticorps anti-M2, AMA) (sous-unit\u00e9s E2 PDC, BCOADC et OGDC)<\/strong><\/li>\n<li><strong>Auto-anticorps anti-gp210<\/strong><\/li>\n<li><strong>Auto-anticorps anti-sp100<\/strong><\/li>\n<\/ul>\n<p><strong>Fr\u00e9quence<\/strong><\/p>\n<p>Quotidienne<\/p>\n<p><strong>Unit\u00e9 de mesure<\/strong><\/p>\n<p>Unit\u00e9s relatives (RE)<\/p>\n<p><strong>Plages de r\u00e9f\u00e9rence<\/strong><br \/>\n&lt; 1 Unit\u00e9s relatives (RE)<\/p>\n<p><strong>Points tarifaires<\/strong><\/p>\n<table border=\"1\">\n<thead>\n<tr>\n<th>Auto-anticorps<\/th>\n<th>Position<\/th>\n<th>P.tarifaires<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Auto-anticorps anti-actine (ql)<\/td>\n<td>1097.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-antig\u00e8nes solubles h\u00e9patiques (SLA) (ql)<\/td>\n<td>1175.00<\/td>\n<td>19.80<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-antig\u00e8nes des microsomes h\u00e9patiques et r\u00e9naux (LKM) (ql)<\/td>\n<td>1147.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps contre l\u2019antig\u00e8ne 1 du cytosol h\u00e9patique (LC1) (ql)<\/td>\n<td style=\"text-align: center;\">&#8211;<\/td>\n<td>gratuit<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-mitochondries (ql)<\/td>\n<td>1157.00<\/td>\n<td>33.30<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-gp210 (1er auto-anticorps, rares) (ql)<\/td>\n<td style=\"text-align: left;\">1192.00<\/td>\n<td>46.80<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-sp-100 (2e auto-anticorps, rares) (ql)<\/td>\n<td>1192.00<\/td>\n<td>46.80<\/td>\n<\/tr>\n<tr>\n<td>TOTAL<\/td>\n<td><\/td>\n<td>213.30<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Domaine de laboratoire\u00a0: Immunologie<\/p>\n<p><strong>ANALYTIQUE<\/strong><\/p>\n<p><strong>M\u00e9thode<\/strong><\/p>\n<p>Spotimmunoassay (SIA), d\u00e9tection des auto-anticorps IgG[\/vc_toggle][vc_toggle title=&#8221;D\u00e9pistage vasculites (ANCA-screen &#8211; Auto-anticorps anti-cytoplasme des neutrophiles)&#8221;]<strong>Objectif du test<\/strong><\/p>\n<p>Mesure des auto-anticorps associ\u00e9s aux vasculites des petits vaisseaux. Des l\u00e9sions se forment dans les petits vaisseaux \u00e0 la suite d&#8217;un processus inflammatoire provoqu\u00e9 par les ANCA. La mesure des anticorps impliqu\u00e9s dans les vasculites des petits vaisseaux (anti-PR3, anti-MPO et anti-MBG) est une <u>analyse d&#8217;urgence<\/u>.<\/p>\n<p>Les principaux auto-anticorps associ\u00e9s aux ANCA :<\/p>\n<ul>\n<li>Anti-PR3 (anti-prot\u00e9inase 3)<\/li>\n<li>Anti-MPO (anti-my\u00e9loperoxydase)<\/li>\n<\/ul>\n<p>Syndrome de Goodpasture :<\/p>\n<ul>\n<li>Anti-MBG (anti-membrane basale glom\u00e9rulaire)<\/li>\n<\/ul>\n<p><strong>Auto-anticorps mesur\u00e9s par l\u2019ANCA-screen :<\/strong><\/p>\n<ul>\n<li><strong>Immunofluorescence indirecte sur les neutrophiles<\/strong><\/li>\n<li><strong>Auto-anticorps anti-PR3<\/strong><\/li>\n<li><strong>Auto-anticorps anti-MPO<\/strong><\/li>\n<li><strong>Auto-anticorps anti-MBG<\/strong><\/li>\n<\/ul>\n<p><strong>Fr\u00e9quence<\/strong><br \/>\nQuotidienne<\/p>\n<p><strong>Unit\u00e9 de mesure<\/strong><\/p>\n<p>Titre (immunofluorescence indirecte sur neutrophiles fix\u00e9s)<br \/>\nUnit\u00e9s relatives (RE) (anti-PR3, anti-MPO et anti-MBG)<\/p>\n<p><strong>Plages de r\u00e9f\u00e9rence<\/strong><\/p>\n<p>Titre &lt; 1:80<br \/>\n&lt; 1 Unit\u00e9s relatives (RE)<\/p>\n<p><strong>Points tarifaires<\/strong><\/p>\n<table border=\"1\">\n<thead>\n<tr>\n<th>Auto-anticorps<\/th>\n<th>Position<\/th>\n<th>P.tarifaires<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Auto-anticorps anti-cytoplasme des neutrophiles (ANCA), screening et typisation des p-ANCA\/c-ANCA\/ANCA atypiques<\/td>\n<td>1161.10<\/td>\n<td>46.80<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps ANCA anti-prot\u00e9inase 3 (PR3-ANCA)<\/td>\n<td>1110.00<\/td>\n<td>25.20<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps ANCA anti my\u00e9lop\u00e9roxydase (MPO-ANCA)<\/td>\n<td>1109.00<\/td>\n<td>25.20<\/td>\n<\/tr>\n<tr>\n<td>Auto-anticorps anti-membrane basale glom\u00e9rulaire<\/td>\n<td>1124.00<\/td>\n<td>46.80<\/td>\n<\/tr>\n<tr>\n<td>TOTAL<\/td>\n<td><\/td>\n<td>144.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Domaine de laboratoire : Immunologie<\/p>\n<p><strong>ANALYTIQUE<\/strong><\/p>\n<p><strong>M\u00e9thode<\/strong><\/p>\n<p>Immunofluorescence indirecte sur neutrophiles fix\u00e9s<br \/>\nSpotimmunoassay (SIA), d\u00e9tection des auto-anticorps IgG[\/vc_toggle][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_toggle title=&#8221;D\u00e9pistage des collag\u00e9noses (anticorps anti-nucl\u00e9aires (ANA) et anti-cytoplasmes)&#8221;]Objectif du test Mesurer les auto-anticorps associ\u00e9s aux collag\u00e9noses. Les collag\u00e9noses sont des maladies rhumatismales inflammatoires syst\u00e9miques dont l&#8217;\u00e9volution est g\u00e9n\u00e9ralement chronique [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":14961,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","footnotes":""},"class_list":["post-15058","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/pages\/15058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/comments?post=15058"}],"version-history":[{"count":0,"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/pages\/15058\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/pages\/14961"}],"wp:attachment":[{"href":"https:\/\/www.immuninlab.ch\/fr\/wp-json\/wp\/v2\/media?parent=15058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}